IMFINZI® (durvalumab) Plus Chemotherapy Approved in the US as the First Immunotherapy Regimen for Patients with Advanced Biliary Tract Cancer – QNT Press Release4 years ago
United States Bus Market Report 2022: An $11.23 Billion Market by 2030 – Increasing Government Initiatives to Adopt Electric Buses – QNT Press Release4 years ago
